ATM-deficient lung, prostate and pancreatic cancer cells are acutely sensitive to the combination of olaparib and the ATR inhibitor AZD6738

MLA

Pinaki Bose, et al. ATM-Deficient Lung, Prostate and Pancreatic Cancer Cells Are Acutely Sensitive to the Combination of Olaparib and the ATR Inhibitor AZD6738. Mar. 2020. EBSCOhost, https://doi.org/10.1101/2020.03.13.991166.

APA

Pinaki Bose, Siddhartha Goutam, Tarek A. Bismar, Nicholas Jette, Suraj Radhamani, Greydon Arthur, Yaping Yu, Steven Yip, Ruiqiong Ye, Michael Paul Kolinsky, Susan P. Lees-Miller, & Mehul Kumar. (2020). ATM-deficient lung, prostate and pancreatic cancer cells are acutely sensitive to the combination of olaparib and the ATR inhibitor AZD6738. https://doi.org/10.1101/2020.03.13.991166

Chicago

Pinaki Bose, Siddhartha Goutam, Tarek A. Bismar, Nicholas Jette, Suraj Radhamani, Greydon Arthur, Yaping Yu, et al. 2020. “ATM-Deficient Lung, Prostate and Pancreatic Cancer Cells Are Acutely Sensitive to the Combination of Olaparib and the ATR Inhibitor AZD6738,” March. doi:10.1101/2020.03.13.991166.